col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Springer Science and Business Media LLC: Nature Communications
  original article Date Title Authors   All Authors
1 [GO] 2021―Jul―27 The trans-omics landscape of COVID-19 Peng Wu, Dongsheng Chen, Wencheng Ding, Ping Wu, Hongyan Hou, Yong Bai, et al. (+64)
2 [GO] 2021―Jul―27 Integrative genomic analyses identify susceptibility genes underlying COVID-19 hospitalization Gita A. Pathak, Kritika Singh, Tyne W. Miller-Fleming, Frank R. Wendt, Nava Ehsan, Kangcheng Hou, et al. (+9)
3 [GO] 2021―Jul―27 Impact of tiered restrictions on human activities and the epidemiology of the second wave of COVID-19 in Italy Mattia Manica, Giorgio Guzzetta, Flavia Riccardo, Antonio Valenti, Piero Poletti, Valentina Marziano, et al. (+14)
4 [GO] 2021―Jul―27 Single-cell transcriptome of bronchoalveolar lavage fluid reveals sequential change of macrophages during SARS-CoV-2 infection in ferrets Jeong Seok Lee, June-Young Koh, Kijong Yi, Young-Il Kim, Su-Jin Park, Eun-Ha Kim, et al. (+5)
5 [GO] 2021―Jul―26 Neutralizing activity of Sputnik V vaccine sera against SARS-CoV-2 variants Satoshi Ikegame, Mohammed N. A. Siddiquey, Chuan-Tien Hung, Griffin Haas, Luca Brambilla, Kasopefoluwa Y. Oguntuyo, et al. (+8)
6 [GO] 2021―Jul―26 Single-cell RNA sequencing reveals ex vivo signatures of SARS-CoV-2-reactive T cells through ‘reverse phenotyping’ David S. Fischer, Meshal Ansari, Karolin I. Wagner, Sebastian Jarosch, Yiqi Huang, Christoph H. Mayr, et al. (+24)
7 [GO] 2021―Jul―20 Development and implementation of a scalable and versatile test for COVID-19 diagnostics in rural communities A. Ceci, C. Muñoz-Ballester, A. N. Tegge, K. L. Brown, R. A. Umans, F. M. Michel, et al. (+11)
8 [GO] 2021―Jul―19 SARS-CoV-2 antibody dynamics and transmission from community-wide serological testing in the Italian municipality of Vo’ Ilaria Dorigatti, Enrico Lavezzo, Laura Manuto, Constanze Ciavarella, Monia Pacenti, Caterina Boldrin, et al. (+30)
9 [GO] 2021―Jul―16 SARS-CoV-2 infection induces the dedifferentiation of multiciliated cells and impairs mucociliary clearance Rémy Robinot, Mathieu Hubert, Guilherme Dias de Melo, Françoise Lazarini, Timothée Bruel, Nikaïa Smith, et al. (+19)
10 [GO] 2021―Jul―16 Associations between dimensions of behaviour, personality traits, and mental-health during the COVID-19 pandemic in the United Kingdom Adam Hampshire, Peter J. Hellyer, Eyal Soreq, Mitul A. Mehta, Konstantinos Ioannidis, William Trender, et al. (+2)
11 [GO] 2021―Jul―14 Oil immersed lossless total analysis system for integrated RNA extraction and detection of SARS-CoV-2 Duane S. Juang, Terry D. Juang, Dawn M. Dudley, Christina M. Newman, Molly A. Accola, William M. Rehrauer, et al. (+3)
12 [GO] 2021―Jul―14 Chronic lung diseases are associated with gene expression programs favoring SARS-CoV-2 entry and severity Linh T. Bui, Nichelle I. Winters, Mei-I Chung, Chitra Joseph, Austin J. Gutierrez, Arun C. Habermann, et al. (+69)
13 [GO] 2021―Jul―13 Reprogrammed CRISPR-Cas13b suppresses SARS-CoV-2 replication and circumvents its mutational escape through mismatch tolerance Mohamed Fareh, Wei Zhao, Wenxin Hu, Joshua M. L. Casan, Amit Kumar, Jori Symons, et al. (+8)
14 [GO] 2021―Jul―09 Potent and protective IGHV3-53/3-66 public antibodies and their shared escape mutant on the spike of SARS-CoV-2 Qi Zhang, Bin Ju, Jiwan Ge, Jasper Fuk-Woo Chan, Lin Cheng, Ruoke Wang, et al. (+23)
15 [GO] 2021―Jul―07 The molecular basis for SARS-CoV-2 binding to dog ACE2 Zengyuan Zhang, Yanfang Zhang, Kefang Liu, Yan Li, Qiong Lu, Qingling Wang, et al. (+16)
16 [GO] 2021―Jul―07 Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies Allison J. Greaney, Tyler N. Starr, Christopher O. Barnes, Yiska Weisblum, Fabian Schmidt, Marina Caskey, et al. (+13)
17 [GO] 2021―Jul―06 Lack of consideration of sex and gender in COVID-19 clinical studies Emer Brady, Mathias Wullum Nielsen, Jens Peter Andersen, Sabine Oertelt-Prigione
18 [GO] 2021―Jul―06 Twelve-month specific IgG response to SARS-CoV-2 receptor-binding domain among COVID-19 convalescent plasma donors in Wuhan Cesheng Li, Ding Yu, Xiao Wu, Hong Liang, Zhijun Zhou, Yong Xie, et al. (+30)
19 [GO] 2021―Jul―05 Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity L. Vanderbeke, P. Van Mol, Y. Van Herck, F. De Smet, S. Humblet-Baron, K. Martinod, et al. (+49)
20 [GO] 2021―Jul―01 Author Correction: Molecular determinants and mechanism for antibody cocktail preventing SARS-CoV-2 escape Zhiqiang Ku, Xuping Xie, Edgar Davidson, Xiaohua Ye, Hang Su, Vineet D. Menachery, et al. (+15)
21 [GO] 2021―Jul―01 The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells D. A. Leach, A. Mohr, E. S. Giotis, E. Cil, A. M. Isac, L. L. Yates, et al. (+4)
22 [GO] 2021―Jun―30 SARS-CoV-2-specific T cell memory is sustained in COVID-19 convalescent patients for 10 months with successful development of stem cell-like memory T cells Jae Hyung Jung, Min-Seok Rha, Moa Sa, Hee Kyoung Choi, Ji Hoon Jeon, Hyeri Seok, et al. (+5)
23 [GO] 2021―Jun―30 CVnCoV and CV2CoV protect human ACE2 transgenic mice from ancestral B BavPat1 and emerging B.1.351 SARS-CoV-2 Donata Hoffmann, Björn Corleis, Susanne Rauch, Nicole Roth, Janine Mühe, Nico Joel Halwe, et al. (+17)
24 [GO] 2021―Jun―28 COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants Pinja Jalkanen, Pekka Kolehmainen, Hanni K. Häkkinen, Moona Huttunen, Paula A. Tähtinen, Rickard Lundberg, et al. (+21)
25 [GO] 2021―Jun―25 Temporal trends of SARS-CoV-2 seroprevalence during the first wave of the COVID-19 epidemic in Kenya Ifedayo M. O. Adetifa, Sophie Uyoga, John N. Gitonga, Daisy Mugo, Mark Otiende, James Nyagwange, et al. (+29)
26 [GO] 2021―Jun―24 The architecture of the SARS-CoV-2 RNA genome inside virion Changchang Cao, Zhaokui Cai, Xia Xiao, Jian Rao, Juan Chen, Naijing Hu, et al. (+8)
27 [GO] 2021―Jun―23 A high-throughput screen for TMPRSS2 expression identifies FDA-approved compounds that can limit SARS-CoV-2 entry Yanwen Chen, Travis B. Lear, John W. Evankovich, Mads B. Larsen, Bo Lin, Irene Alfaras, et al. (+11)
28 [GO] 2021―Jun―23 COVseq is a cost-effective workflow for mass-scale SARS-CoV-2 genomic surveillance Michele Simonetti, Ning Zhang, Luuk Harbers, Maria Grazia Milia, Silvia Brossa, Thi Thu Huong Nguyen, et al. (+7)
29 [GO] 2021―Jun―22 Author Correction: A high-throughput neutralizing antibody assay for COVID-19 diagnosis and vaccine evaluation Antonio E. Muruato, Camila R. Fontes-Garfias, Ping Ren, Mariano A. Garcia-Blanco, Vineet D. Menachery, Xuping Xie, Pei-Yong Shi
30 [GO] 2021―Jun―22 Evaluating the climate impact of aviation emission scenarios towards the Paris agreement including COVID-19 effects Volker Grewe, Arvind Gangoli Rao, Tomas Grönstedt, Carlos Xisto, Florian Linke, Joris Melkert, et al. (+6)
31 [GO] 2021―Jun―21 Author Correction: A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19 Xuping Xie, Antonio E. Muruato, Xianwen Zhang, Kumari G. Lokugamage, Camila R. Fontes-Garfias, Jing Zou, et al. (+9)
32 [GO] 2021―Jun―21 Engineered ACE2 receptor therapy overcomes mutational escape of SARS-CoV-2 Yusuke Higuchi, Tatsuya Suzuki, Takao Arimori, Nariko Ikemura, Emiko Mihara, Yuhei Kirita, et al. (+12)
33 [GO] 2021―Jun―21 Sequence signatures of two public antibody clonotypes that bind SARS-CoV-2 receptor binding domain Timothy J. C. Tan, Meng Yuan, Kaylee Kuzelka, Gilberto C. Padron, Jacob R. Beal, Xin Chen, et al. (+7)
34 [GO] 2021―Jun―21 SARS-CoV-2-mediated dysregulation of metabolism and autophagy uncovers host-targeting antivirals Nils C. Gassen, Jan Papies, Thomas Bajaj, Jackson Emanuel, Frederik Dethloff, Robert Lorenz Chua, et al. (+29)
35 [GO] 2021―Jun―18 Association of social distancing and face mask use with risk of COVID-19 Sohee Kwon, Amit D. Joshi, Chun-Han Lo, David A. Drew, Long H. Nguyen, Chuan-Guo Guo, et al. (+15)
36 [GO] 2021―Jun―18 Emission impacts of China’s solid waste import ban and COVID-19 in the copper supply chain John Ryter, Xinkai Fu, Karan Bhuwalka, Richard Roth, Elsa A. Olivetti
37 [GO] 2021―Jun―18 Community factors and excess mortality in first wave of the COVID-19 pandemic in England Bethan Davies, Brandon L. Parkes, James Bennett, Daniela Fecht, Marta Blangiardo, Majid Ezzati, Paul Elliott
38 [GO] 2021―Jun―18 Immunological imprinting of the antibody response in COVID-19 patients Teresa Aydillo, Alexander Rombauts, Daniel Stadlbauer, Sadaf Aslam, Gabriela Abelenda-Alonso, Alba Escalera, et al. (+5)
39 [GO] 2021―Jun―18 Design of COVID-19 staged alert systems to ensure healthcare capacity with minimal closures Haoxiang Yang, Özge Sürer, Daniel Duque, David P. Morton, Bismark Singh, Spencer J. Fox, et al. (+10)
40 [GO] 2021―Jun―17 Neighborhood-level disparities and subway utilization during the COVID-19 pandemic in New York City Daniel Carrión, Elena Colicino, Nicolo Foppa Pedretti, Kodi B. Arfer, Johnathan Rush, Nicholas DeFelice, Allan C. Just
41 [GO] 2021―Jun―17 Combining machine learning and nanopore construction creates an artificial intelligence nanopore for coronavirus detection Masateru Taniguchi, Shohei Minami, Chikako Ono, Rina Hamajima, Ayumi Morimura, Shigeto Hamaguchi, et al. (+16)
42 [GO] 2021―Jun―17 Multianalyte serology in home-sampled blood enables an unbiased assessment of the immune response against SARS-CoV-2 Niclas Roxhed, Annika Bendes, Matilda Dale, Cecilia Mattsson, Leo Hanke, Tea Dodig-Crnković, et al. (+15)
43 [GO] 2021―Jun―16 Effect of COVID-19 response policies on walking behavior in US cities Ruth F. Hunter, Leandro Garcia, Thiago Herick de Sa, Belen Zapata-Diomedi, Christopher Millett, James Woodcock, et al. (+2)
44 [GO] 2021―Jun―16 Multivalency transforms SARS-CoV-2 antibodies into ultrapotent neutralizers Edurne Rujas, Iga Kucharska, Yong Zi Tan, Samir Benlekbir, Hong Cui, Tiantian Zhao, et al. (+20)
45 [GO] 2021―Jun―16 Modeling the effectiveness of olfactory testing to limit SARS-CoV-2 transmission Daniel B. Larremore, Derek Toomre, Roy Parker
46 [GO] 2021―Jun―16 Controlling the pandemic during the SARS-CoV-2 vaccination rollout João Viana, Christiaan H. van Dorp, Ana Nunes, Manuel C. Gomes, Michiel van Boven, Mirjam E. Kretzschmar, et al. (+2)
47 [GO] 2021―Jun―15 Identification of pyrogallol as a warhead in design of covalent inhibitors for the SARS-CoV-2 3CL protease Haixia Su, Sheng Yao, Wenfeng Zhao, Yumin Zhang, Jia Liu, Qiang Shao, et al. (+13)
48 [GO] 2021―Jun―15 Molecular benchmarks of a SARS-CoV-2 epidemic Hakon Jonsson, Olafur T. Magnusson, Pall Melsted, Jonas Berglund, Arna B. Agustsdottir, Berglind Eiríksdottir, et al. (+41)
49 [GO] 2021―Jun―15 Insights into household transmission of SARS-CoV-2 from a population-based serological survey Qifang Bi, Justin Lessler, Isabella Eckerle, Stephen A. Lauer, Laurent Kaiser, Nicolas Vuilleumier, et al. (+68)
50 [GO] 2021―Jun―14 Role of meteorological factors in the transmission of SARS-CoV-2 in the United States Yiqun Ma, Sen Pei, Jeffrey Shaman, Robert Dubrow, Kai Chen
51 [GO] 2021―Jun―14 SARS-CoV-2 infection and transmission in the North American deer mouse Bryan D. Griffin, Mable Chan, Nikesh Tailor, Emelissa J. Mendoza, Anders Leung, Bryce M. Warner, et al. (+22)
52 [GO] 2021―Jun―11 SARS-CoV-2 RBD trimer protein adjuvanted with Alum-3M-052 protects from SARS-CoV-2 infection and immune pathology in the lung Nanda Kishore Routhu, Narayanaiah Cheedarla, Venkata Satish Bollimpelli, Sailaja Gangadhara, Venkata Viswanadh Edara, Lilin Lai, et al. (+19)
53 [GO] 2021―Jun―11 Distinct clinical and immunological profiles of patients with evidence of SARS-CoV-2 infection in sub-Saharan Africa Ben Morton, Kayla G. Barnes, Catherine Anscombe, Khuzwayo Jere, Prisca Matambo, Jonathan Mandolo, et al. (+59)
54 [GO] 2021―Jun―11 Citywide serosurveillance of the initial SARS-CoV-2 outbreak in San Francisco using electronic health records Isobel Routledge, Adrienne Epstein, Saki Takahashi, Owen Janson, Jill Hakim, Elias Duarte, et al. (+21)
55 [GO] 2021―Jun―11 Effect of specific non-pharmaceutical intervention policies on SARS-CoV-2 transmission in the counties of the United States Bingyi Yang, Angkana T. Huang, Bernardo Garcia-Carreras, William E. Hart, Andrea Staid, Matt D. T. Hitchings, et al. (+31)
56 [GO] 2021―Jun―10 Viral infiltration of pancreatic islets in patients with COVID-19 Charlotte Steenblock, Stefanie Richter, Ilona Berger, Marko Barovic, Janine Schmid, Undine Schubert, et al. (+16)
57 [GO] 2021―Jun―09 Clinical and molecular characteristics of COVID-19 patients with persistent SARS-CoV-2 infection Bin Yang, Junpeng Fan, Jia Huang, Ensong Guo, Yu Fu, Si Liu, et al. (+16)
58 [GO] 2021―Jun―08 Optimizing vaccine allocation for COVID-19 vaccines shows the potential role of single-dose vaccination Laura Matrajt, Julia Eaton, Tiffany Leung, Dobromir Dimitrov, Joshua T. Schiffer, David A. Swan, Holly Janes
59 [GO] 2021―Jun―08 A versatile reverse genetics platform for SARS-CoV-2 and other positive-strand RNA viruses Alberto A. Amarilla, Julian D. J. Sng, Rhys Parry, Joshua M. Deerain, James R. Potter, Yin Xiang Setoh, et al. (+25)
60 [GO] 2021―Jun―08 Structural basis for SARS-CoV-2 envelope protein recognition of human cell junction protein PALS1 Jin Chai, Yuanheng Cai, Changxu Pang, Liguo Wang, Sean McSweeney, John Shanklin, Qun Liu
61 [GO] 2021―Jun―08 Molecular evidence of SARS-CoV-2 in New York before the first pandemic wave Matthew M. Hernandez, Ana S. Gonzalez-Reiche, Hala Alshammary, Shelcie Fabre, Zenab Khan, Adriana van De Guchte, et al. (+20)
62 [GO] 2021―Jun―07 SARS-CoV-2 RNAemia and proteomic trajectories inform prognostication in COVID-19 patients admitted to intensive care Clemens Gutmann, Kaloyan Takov, Sean A. Burnap, Bhawana Singh, Hashim Ali, Konstantinos Theofilatos, et al. (+31)
63 [GO] 2021―Jun―03 Drug repurposing screens identify chemical entities for the development of COVID-19 interventions Malina A. Bakowski, Nathan Beutler, Karen C. Wolff, Melanie G. Kirkpatrick, Emily Chen, Tu-Trinh H. Nguyen, et al. (+26)
64 [GO] 2021―Jun―02 A metal ion orients SARS-CoV-2 mRNA to ensure accurate 2′-O methylation of its first nucleotide Thiruselvam Viswanathan, Anurag Misra, Siu-Hong Chan, Shan Qi, Nan Dai, Shailee Arya, et al. (+2)
65 [GO] 2021―May―31 Impact of COVID-19 outbreaks and interventions on influenza in China and the United States Luzhao Feng, Ting Zhang, Qing Wang, Yiran Xie, Zhibin Peng, Jiandong Zheng, et al. (+7)
66 [GO] 2021―May―27 Effects of potent neutralizing antibodies from convalescent plasma in patients hospitalized for severe SARS-CoV-2 infection Arvind Gharbharan, Carlijn C. E. Jordans, Corine GeurtsvanKessel, Jan G. den Hollander, Faiz Karim, Femke P. N. Mollema, et al. (+26)
67 [GO] 2021―May―25 Impacts of social distancing policies on mobility and COVID-19 case growth in the US Gregory A. Wellenius, Swapnil Vispute, Valeria Espinosa, Alex Fabrikant, Thomas C. Tsai, Jonathan Hennessy, et al. (+23)
68 [GO] 2021―May―25 Multiplexed detection of SARS-CoV-2 and other respiratory infections in high throughput by SARSeq Ramesh Yelagandula, Aleksandr Bykov, Alexander Vogt, Robert Heinen, Ezgi Özkan, Marcus Martin Strobl, et al. (+16)
69 [GO] 2021―May―25 Immune response to SARS-CoV-2 variants of concern in vaccinated individuals Matthias Becker, Alex Dulovic, Daniel Junker, Natalia Ruetalo, Philipp D. Kaiser, Yudi T. Pinilla, et al. (+20)
70 [GO] 2021―May―24 Inhibition mechanism of SARS-CoV-2 main protease by ebselen and its derivatives Kangsa Amporndanai, Xiaoli Meng, Weijuan Shang, Zhenmig Jin, Michael Rogers, Yao Zhao, et al. (+6)
71 [GO] 2021―May―21 Severe T cell hyporeactivity in ventilated COVID-19 patients correlates with prolonged virus persistence and poor outcomes Kerstin Renner, Tobias Schwittay, Sophia Chaabane, Johanna Gottschling, Christine Müller, Charlotte Tiefenböck, et al. (+19)
72 [GO] 2021―May―21 Peripheral and lung resident memory T cell responses against SARS-CoV-2 Judith Grau-Expósito, Nerea Sánchez-Gaona, Núria Massana, Marina Suppi, Antonio Astorga-Gamaza, David Perea, et al. (+20)
73 [GO] 2021―May―21 Prevalence of SARS-CoV-2 antibodies in France: results from nationwide serological surveillance Stéphane Le Vu, Gabrielle Jones, François Anna, Thierry Rose, Jean-Baptiste Richard, Sibylle Bernard-Stoecklin, et al. (+17)
74 [GO] 2021―May―20 Controlling COVID-19 via test-trace-quarantine Cliff C. Kerr, Dina Mistry, Robyn M. Stuart, Katherine Rosenfeld, Gregory R. Hart, Rafael C. Núñez, et al. (+11)
75 [GO] 2021―May―19 Cross-reactive serum and memory B-cell responses to spike protein in SARS-CoV-2 and endemic coronavirus infection Ge Song, Wan-ting He, Sean Callaghan, Fabio Anzanello, Deli Huang, James Ricketts, et al. (+15)
76 [GO] 2021―May―18 A rapid, accurate, scalable, and portable testing system for COVID-19 diagnosis Guanhua Xun, Stephan Thomas Lane, Vassily Andrew Petrov, Brandon Elliott Pepa, Huimin Zhao
77 [GO] 2021―May―14 Author Correction: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials Cathrine Axfors, Andreas M. Schmitt, Perrine Janiaud, Janneke van’t Hooft, Sherief Abd-Elsalam, Ehab F. Abdo, et al. (+88)
78 [GO] 2021―May―14 Author Correction: Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor Jinsung Yang, Simon J. L. Petitjean, Melanie Koehler, Qingrong Zhang, Andra C. Dumitru, Wenzhang Chen, et al. (+4)
79 [GO] 2021―May―14 Crystal structure of SARS-CoV-2 Orf9b in complex with human TOM70 suggests unusual virus-host interactions Xiaopan Gao, Kaixiang Zhu, Bo Qin, Vincent Olieric, Meitian Wang, Sheng Cui
80 [GO] 2021―May―13 Characterization of an attenuated SARS-CoV-2 variant with a deletion at the S1/S2 junction of the spike protein Pui Wang, Siu-Ying Lau, Shaofeng Deng, Pin Chen, Bobo Wing-Yee Mok, Anna Jinxia Zhang, et al. (+12)
81 [GO] 2021―May―12 Estimating COVID-19 mortality in Italy early in the COVID-19 pandemic Chirag Modi, Vanessa Böhm, Simone Ferraro, George Stein, Uroš Seljak
82 [GO] 2021―May―12 The epidemicity index of recurrent SARS-CoV-2 infections Lorenzo Mari, Renato Casagrandi, Enrico Bertuzzo, Damiano Pasetto, Stefano Miccoli, Andrea Rinaldo, Marino Gatto
83 [GO] 2021―May―11 Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival Stefania Dispinseri, Massimiliano Secchi, Maria Franca Pirillo, Monica Tolazzi, Martina Borghi, Cristina Brigatti, et al. (+14)
84 [GO] 2021―May―11 SARS-CoV-2 gene content and COVID-19 mutation impact by comparing 44 Sarbecovirus genomes Irwin Jungreis, Rachel Sealfon, Manolis Kellis
85 [GO] 2021―May―11 A SARS-CoV-2 antibody curbs viral nucleocapsid protein-induced complement hyperactivation Sisi Kang, Mei Yang, Suhua He, Yueming Wang, Xiaoxue Chen, Yao-Qing Chen, et al. (+14)
86 [GO] 2021―May―11 A SARS-CoV-2 neutralizing antibody with extensive Spike binding coverage and modified for optimal therapeutic outcomes Yu Guo, Lisu Huang, Guangshun Zhang, Yanfeng Yao, He Zhou, Shu Shen, et al. (+42)
87 [GO] 2021―May―10 Predictive performance of international COVID-19 mortality forecasting models Joseph Friedman, Patrick Liu, Christopher E. Troeger, Austin Carter, Robert C. Reiner, Ryan M. Barber, et al. (+7)
88 [GO] 2021―May―10 Author Correction: Rapid decline of neutralizing antibodies against SARS-CoV-2 among infected healthcare workers Stéphane Marot, Isabelle Malet, Valentin Leducq, Karen Zafilaza, Delphine Sterlin, Delphine Planas, et al. (+10)
89 [GO] 2021―May―10 Identification and characterization of a SARS-CoV-2 specific CD8+ T cell response with immunodominant features Anastasia Gangaev, Steven L. C. Ketelaars, Olga I. Isaeva, Sanne Patiwael, Anna Dopler, Kelly Hoefakker, et al. (+14)
90 [GO] 2021―May―05 Author Correction: Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors Sho Iketani, Farhad Forouhar, Hengrui Liu, Seo Jung Hong, Fang-Yu Lin, Manoj S. Nair, et al. (+6)
91 [GO] 2021―May―04 Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 infection Bo Diao, Chenhui Wang, Rongshuai Wang, Zeqing Feng, Ji Zhang, Han Yang, et al. (+12)
92 [GO] 2021―Apr―30 Author Correction: Infectivity, susceptibility, and risk factors associated with SARS-CoV-2 transmission under intensive contact tracing in Hunan, China Shixiong Hu, Wei Wang, Yan Wang, Maria Litvinova, Kaiwei Luo, Lingshuang Ren, et al. (+23)
93 [GO] 2021―Apr―27 Tracking the global reduction of marine traffic during the COVID-19 pandemic David March, Kristian Metcalfe, Joaquin Tintoré, Brendan J. Godley
94 [GO] 2021―Apr―23 Estimating the effect of social inequalities on the mitigation of COVID-19 across communities in Santiago de Chile Nicolò Gozzi, Michele Tizzoni, Matteo Chinazzi, Leo Ferres, Alessandro Vespignani, Nicola Perra
95 [GO] 2021―Apr―23 COVID-19 pathophysiology may be driven by an imbalance in the renin-angiotensin-aldosterone system Susanne Rysz, Jonathan Al-Saadi, Anna Sjöström, Maria Farm, Francesca Campoccia Jalde, Michael Plattén, et al. (+9)
96 [GO] 2021―Apr―22 Leveraging community mortality indicators to infer COVID-19 mortality and transmission dynamics in Damascus, Syria Oliver J. Watson, Mervat Alhaffar, Zaki Mehchy, Charles Whittaker, Zack Akil, Nicholas F. Brazeau, et al. (+17)
97 [GO] 2021―Apr―16 Orally delivered MK-4482 inhibits SARS-CoV-2 replication in the Syrian hamster model Kyle Rosenke, Frederick Hansen, Benjamin Schwarz, Friederike Feldmann, Elaine Haddock, Rebecca Rosenke, et al. (+11)
98 [GO] 2021―Apr―15 Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials Cathrine Axfors, Andreas M. Schmitt, Perrine Janiaud, Janneke van’t Hooft, Sherief Abd-Elsalam, Ehab F. Abdo, et al. (+88)
99 [GO] 2021―Apr―15 Publisher Correction: A single-dose mRNA vaccine provides a long-term protection for hACE2 transgenic mice from SARS-CoV-2 Qingrui Huang, Kai Ji, Siyu Tian, Fengze Wang, Baoying Huang, Zhou Tong, et al. (+6)
100 [GO] 2021―Apr―15 The effect of eviction moratoria on the transmission of SARS-CoV-2 Anjalika Nande, Justin Sheen, Emma L. Walters, Brennan Klein, Matteo Chinazzi, Andrei H. Gheorghe, et al. (+9)
101 [GO] 2021―Apr―12 Genetic evidence for the association between COVID-19 epidemic severity and timing of non-pharmaceutical interventions Manon Ragonnet-Cronin, Olivia Boyd, Lily Geidelberg, David Jorgensen, Fabricia F. Nascimento, Igor Siveroni, et al. (+10)
102 [GO] 2021―Apr―09 IL-33 expression in response to SARS-CoV-2 correlates with seropositivity in COVID-19 convalescent individuals Michal A. Stanczak, David E. Sanin, Petya Apostolova, Gabriele Nerz, Dimitrios Lampaki, Maike Hofmann, et al. (+7)
103 [GO] 2021―Apr―09 Seroprevalence and correlates of SARS-CoV-2 neutralizing antibodies from a population-based study in Bonn, Germany N. Ahmad Aziz, Victor M. Corman, Antje K. C. Echterhoff, Marcel A. Müller, Anja Richter, Antonio Schmandke, et al. (+5)
104 [GO] 2021―Apr―09 GCG inhibits SARS-CoV-2 replication by disrupting the liquid phase condensation of its nucleocapsid protein Ming Zhao, Yu Yu, Li-Ming Sun, Jia-Qing Xing, Tingting Li, Yunkai Zhu, et al. (+15)
105 [GO] 2021―Apr―08 Author Correction: Infectivity, susceptibility, and risk factors associated with SARS-CoV-2 transmission under intensive contact tracing in Hunan, China Shixiong Hu, Wei Wang, Yan Wang, Maria Litvinova, Kaiwei Luo, Lingshuang Ren, et al. (+23)
106 [GO] 2021―Apr―07 A conversation on the effects of the COVID-19 pandemic on academic careers with junior researchers
107 [GO] 2021―Apr―07 A conversation on the effects of the COVID-19 pandemic on junior researchers’ careers with funders and university leaders
108 [GO] 2021―Apr―06 T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses Ane Ogbe, Barbara Kronsteiner, Donal T. Skelly, Matthew Pace, Anthony Brown, Emily Adland, et al. (+55)
109 [GO] 2021―Apr―01 Systems serology detects functionally distinct coronavirus antibody features in children and elderly Kevin J. Selva, Carolien E. van de Sandt, Melissa M. Lemke, Christina Y. Lee, Suzanne K. Shoffner, Brendon Y. Chua, et al. (+35)
110 [GO] 2021―Apr―01 Author Correction: Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV Xiuyuan Ou, Yan Liu, Xiaobo Lei, Pei Li, Dan Mi, Lili Ren, et al. (+12)
111 [GO] 2021―Apr―01 Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors Sho Iketani, Farhad Forouhar, Hengrui Liu, Seo Jung Hong, Fang-Yu Lin, Manoj S. Nair, et al. (+6)
112 [GO] 2021―Mar―30 SARS-CoV-2 in severe COVID-19 induces a TGF-β-dominated chronic immune response that does not target itself Marta Ferreira-Gomes, Andrey Kruglov, Pawel Durek, Frederik Heinrich, Caroline Tizian, Gitta Anne Heinz, et al. (+36)
113 [GO] 2021―Mar―30 Peginterferon Lambda-1a for treatment of outpatients with uncomplicated COVID-19: a randomized placebo-controlled trial Prasanna Jagannathan, Jason R. Andrews, Hector Bonilla, Haley Hedlin, Karen B. Jacobson, Vidhya Balasubramanian, et al. (+21)
114 [GO] 2021―Mar―29 A haemagglutination test for rapid detection of antibodies to SARS-CoV-2 Alain Townsend, Pramila Rijal, Julie Xiao, Tiong Kit Tan, Kuan-Ying A. Huang, Lisa Schimanski, et al. (+57)
115 [GO] 2021―Mar―29 The SARS-CoV-2 nucleocapsid protein is dynamic, disordered, and phase separates with RNA Jasmine Cubuk, Jhullian J. Alston, J. Jeremías Incicco, Sukrit Singh, Melissa D. Stuchell-Brereton, Michael D. Ward, et al. (+8)
116 [GO] 2021―Mar―29 Implications of the school-household network structure on SARS-CoV-2 transmission under school reopening strategies in England James D. Munday, Katharine Sherratt, Sophie Meakin, Akira Endo, Carl A. B. Pearson, Joel Hellewell, et al. (+7)
117 [GO] 2021―Mar―26 Hospital load and increased COVID-19 related mortality in Israel Hagai Rossman, Tomer Meir, Jonathan Somer, Smadar Shilo, Rom Gutman, Asaf Ben Arie, et al. (+3)
118 [GO] 2021―Mar―26 N-protein presents early in blood, dried blood and saliva during asymptomatic and symptomatic SARS-CoV-2 infection Dandan Shan, Joseph M. Johnson, Syrena C. Fernandes, Hannah Suib, Soyoon Hwang, Danica Wuelfing, et al. (+19)
119 [GO] 2021―Mar―25 SARS-CoV-2 infection rewires host cell metabolism and is potentially susceptible to mTORC1 inhibition Peter J. Mullen, Gustavo Garcia, Arunima Purkayastha, Nedas Matulionis, Ernst W. Schmid, Milica Momcilovic, et al. (+10)
120 [GO] 2021―Mar―22 SARS-CoV-2 infection induces sustained humoral immune responses in convalescent patients following symptomatic COVID-19 Jun Wu, Boyun Liang, Cunrong Chen, Hua Wang, Yaohui Fang, Shu Shen, et al. (+22)
121 [GO] 2021―Mar―19 An engineered CRISPR-Cas12a variant and DNA-RNA hybrid guides enable robust and rapid COVID-19 testing Kean Hean Ooi, Mengying Mandy Liu, Jie Wen Douglas Tay, Seok Yee Teo, Pornchai Kaewsapsak, Shengyang Jin, et al. (+8)
122 [GO] 2021―Mar―19 Exposure to SARS-CoV-2 generates T-cell memory in the absence of a detectable viral infection Zhongfang Wang, Xiaoyun Yang, Jiaying Zhong, Yumin Zhou, Zhiqiang Tang, Haibo Zhou, et al. (+9)
123 [GO] 2021―Mar―19 Favipiravir antiviral efficacy against SARS-CoV-2 in a hamster model Jean-Sélim Driouich, Maxime Cochin, Guillaume Lingas, Grégory Moureau, Franck Touret, Paul-Rémi Petit, et al. (+8)
124 [GO] 2021―Mar―19 Alpha-1 antitrypsin inhibits TMPRSS2 protease activity and SARS-CoV-2 infection Lukas Wettstein, Tatjana Weil, Carina Conzelmann, Janis A. Müller, Rüdiger Groß, Maximilian Hirschenberger, et al. (+24)
125 [GO] 2021―Mar―17 A conserved immunogenic and vulnerable site on the coronavirus spike protein delineated by cross-reactive monoclonal antibodies Chunyan Wang, Rien van Haperen, Javier Gutiérrez-Álvarez, Wentao Li, Nisreen M. A. Okba, Irina Albulescu, et al. (+12)
126 [GO] 2021―Mar―15 SARS-CoV-2 hijacks folate and one-carbon metabolism for viral replication Yuchen Zhang, Rui Guo, Sharon H. Kim, Hardik Shah, Shuting Zhang, Jin Hua Liang, et al. (+7)
127 [GO] 2021―Mar―12 Model-based evaluation of school- and non-school-related measures to control the COVID-19 pandemic Ganna Rozhnova, Christiaan H. van Dorp, Patricia Bruijning-Verhagen, Martin C. J. Bootsma, Janneke H. H. M. van de Wijgert, Marc J. M. Bonten, Mirjam E. Kretzschmar
128 [GO] 2021―Mar―12 Integrated cytokine and metabolite analysis reveals immunometabolic reprogramming in COVID-19 patients with therapeutic implications Nan Xiao, Meng Nie, Huanhuan Pang, Bohong Wang, Jieli Hu, Xiangjun Meng, et al. (+9)
129 [GO] 2021―Mar―12 SARS-CoV and SARS-CoV-2 are transmitted through the air between ferrets over more than one meter distance Jasmin S. Kutter, Dennis de Meulder, Theo M. Bestebroer, Pascal Lexmond, Ard Mulders, Mathilde Richard, et al. (+2)
130 [GO] 2021―Mar―12 Shotgun transcriptome, spatial omics, and isothermal profiling of SARS-CoV-2 infection reveals unique host responses, viral diversification, and drug interactions Daniel Butler, Christopher Mozsary, Cem Meydan, Jonathan Foox, Joel Rosiene, Alon Shaiber, et al. (+73)
131 [GO] 2021―Mar―12 Evaluating the impact of curfews and other measures on SARS-CoV-2 transmission in French Guiana Alessio Andronico, Cécile Tran Kiem, Juliette Paireau, Tiphanie Succo, Paolo Bosetti, Noémie Lefrancq, et al. (+7)
132 [GO] 2021―Mar―12 Digital proximity tracing on empirical contact networks for pandemic control G. Cencetti, G. Santin, A. Longa, E. Pigani, A. Barrat, C. Cattuto, et al. (+3)
133 [GO] 2021―Mar―11 Bat and pangolin coronavirus spike glycoprotein structures provide insights into SARS-CoV-2 evolution Shuyuan Zhang, Shuyuan Qiao, Jinfang Yu, Jianwei Zeng, Sisi Shan, Long Tian, et al. (+3)
134 [GO] 2021―Mar―11 SARS-CoV-2 neutralizing human recombinant antibodies selected from pre-pandemic healthy donors binding at RBD-ACE2 interface Federico Bertoglio, Doris Meier, Nora Langreder, Stephan Steinke, Ulfert Rand, Luca Simonelli, et al. (+30)
135 [GO] 2021―Mar―10 Author Correction: Evidence for SARS-CoV-2 related coronaviruses circulating in bats and pangolins in Southeast Asia Supaporn Wacharapluesadee, Chee Wah Tan, Patarapol Maneeorn, Prateep Duengkae, Feng Zhu, Yutthana Joyjinda, et al. (+18)
136 [GO] 2021―Mar―09 The impact of contact tracing and household bubbles on deconfinement strategies for COVID-19 Lander Willem, Steven Abrams, Pieter J. K. Libin, Pietro Coletti, Elise Kuylen, Oana Petrof, et al. (+6)
137 [GO] 2021―Mar―09 Cross-linking peptide and repurposed drugs inhibit both entry pathways of SARS-CoV-2 Hanjun Zhao, Kelvin K. W. To, Hoiyan Lam, Xinxin Zhou, Jasper Fuk-Woo Chan, Zheng Peng, et al. (+10)
138 [GO] 2021―Mar―09 Infectivity, susceptibility, and risk factors associated with SARS-CoV-2 transmission under intensive contact tracing in Hunan, China Shixiong Hu, Wei Wang, Yan Wang, Maria Litvinova, Kaiwei Luo, Lingshuang Ren, et al. (+23)
139 [GO] 2021―Mar―08 Real-time tracking and prediction of COVID-19 infection using digital proxies of population mobility and mixing Kathy Leung, Joseph T. Wu, Gabriel M. Leung
140 [GO] 2021―Mar―05 Author Correction: Potential health and economic impacts of dexamethasone treatment for patients with COVID-19 Ricardo Águas, Adam Mahdi, Rima Shretta, Peter Horby, Martin Landray, Lisa White
141 [GO] 2021―Mar―05 Deciphering the state of immune silence in fatal COVID-19 patients Pierre Bost, Francesco De Sanctis, Stefania Canè, Stefano Ugel, Katia Donadello, Monica Castellucci, et al. (+18)
142 [GO] 2021―Mar―05 Point-of-care bulk testing for SARS-CoV-2 by combining hybridization capture with improved colorimetric LAMP Lukas Bokelmann, Olaf Nickel, Tomislav Maricic, Svante Pääbo, Matthias Meyer, Stephan Borte, Stephan Riesenberg
143 [GO] 2021―Mar―03 A multiplexed, next generation sequencing platform for high-throughput detection of SARS-CoV-2 Marie-Ming Aynaud, J. Javier Hernandez, Seda Barutcu, Ulrich Braunschweig, Kin Chan, Joel D. Pearson, et al. (+17)
144 [GO] 2021―Mar―03 Immunogenicity of prime-boost protein subunit vaccine strategies against SARS-CoV-2 in mice and macaques Hyon-Xhi Tan, Jennifer A. Juno, Wen Shi Lee, Isaac Barber-Axthelm, Hannah G. Kelly, Kathleen M. Wragg, et al. (+6)
145 [GO] 2021―Mar―02 The prevalence of antibodies to SARS-CoV-2 among blood donors in China Le Chang, Wangheng Hou, Lei Zhao, Yali Zhang, Yanbin Wang, Linfeng Wu, et al. (+21)
146 [GO] 2021―Mar―02 Immunogenicity and protective efficacy of inactivated SARS-CoV-2 vaccine candidate, BBV152 in rhesus macaques Pragya D. Yadav, Raches Ella, Sanjay Kumar, Dilip R. Patil, Sreelekshmy Mohandas, Anita M. Shete, et al. (+39)
147 [GO] 2021―Mar―01 S-Trimer, a COVID-19 subunit vaccine candidate, induces protective immunity in nonhuman primates Joshua G. Liang, Danmei Su, Tian-Zhang Song, Yilan Zeng, Weijin Huang, Jinhua Wu, et al. (+19)
148 [GO] 2021―Feb―26 Association between antecedent statin use and decreased mortality in hospitalized patients with COVID-19 Aakriti Gupta, Mahesh V. Madhavan, Timothy J. Poterucha, Ersilia M. DeFilippis, Jessica A. Hennessey, Bjorn Redfors, et al. (+23)
149 [GO] 2021―Feb―26 Orchestrating performance of healthcare networks subjected to the compound events of natural disasters and pandemic Emad M. Hassan, Hussam N. Mahmoud
150 [GO] 2021―Feb―24 Comparison of rhesus and cynomolgus macaques as an infection model for COVID-19 Francisco J. Salguero, Andrew D. White, Gillian S. Slack, Susan A. Fotheringham, Kevin R. Bewley, Karen E. Gooch, et al. (+58)
151 [GO] 2021―Feb―22 Antibody affinity maturation and plasma IgA associate with clinical outcome in hospitalized COVID-19 patients Juanjie Tang, Supriya Ravichandran, Youri Lee, Gabrielle Grubbs, Elizabeth M. Coyle, Laura Klenow, et al. (+3)
152 [GO] 2021―Feb―20 Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19 Adam K. Wheatley, Jennifer A. Juno, Jing J. Wang, Kevin J. Selva, Arnold Reynaldi, Hyon-Xhi Tan, et al. (+16)
153 [GO] 2021―Feb―20 Harnessing peak transmission around symptom onset for non-pharmaceutical intervention and containment of the COVID-19 pandemic Liang Tian, Xuefei Li, Fei Qi, Qian-Yuan Tang, Viola Tang, Jiang Liu, et al. (+6)
154 [GO] 2021―Feb―20 Exploring beyond clinical routine SARS-CoV-2 serology using MultiCoV-Ab to evaluate endemic coronavirus cross-reactivity Matthias Becker, Monika Strengert, Daniel Junker, Philipp D. Kaiser, Tobias Kerrinnes, Bjoern Traenkle, et al. (+30)
155 [GO] 2021―Feb―20 Predicting mammalian hosts in which novel coronaviruses can be generated Maya Wardeh, Matthew Baylis, Marcus S. C. Blagrove
156 [GO] 2021―Feb―20 Interleukin-3 is a predictive marker for severity and outcome during SARS-CoV-2 infections Alan Bénard, Anne Jacobsen, Maximilian Brunner, Christian Krautz, Bettina Klösch, Izabela Swierzy, et al. (+25)
157 [GO] 2021―Feb―19 Reduction in mobility and COVID-19 transmission Pierre Nouvellet, Sangeeta Bhatia, Anne Cori, Kylie E. C. Ainslie, Marc Baguelin, Samir Bhatt, et al. (+45)
158 [GO] 2021―Feb―19 Dysregulated transcriptional responses to SARS-CoV-2 in the periphery Micah T. McClain, Florica J. Constantine, Ricardo Henao, Yiling Liu, Ephraim L. Tsalik, Thomas W. Burke, et al. (+14)
159 [GO] 2021―Feb―19 Innate cell profiles during the acute and convalescent phase of SARS-CoV-2 infection in children Melanie R. Neeland, Samantha Bannister, Vanessa Clifford, Kate Dohle, Kim Mulholland, Philip Sutton, et al. (+6)
160 [GO] 2021―Feb―17 Real-time prediction of COVID-19 related mortality using electronic health records Patrick Schwab, Arash Mehrjou, Sonali Parbhoo, Leo Anthony Celi, Jürgen Hetzel, Markus Hofer, et al. (+2)
161 [GO] 2021―Feb―17 Discrete SARS-CoV-2 antibody titers track with functional humoral stability Yannic C. Bartsch, Stephanie Fischinger, Sameed M. Siddiqui, Zhilin Chen, Jingyou Yu, Makda Gebre, et al. (+24)
162 [GO] 2021―Feb―17 Causal network models of SARS-CoV-2 expression and aging to identify candidates for drug repurposing Anastasiya Belyaeva, Louis Cammarata, Adityanarayanan Radhakrishnan, Chandler Squires, Karren Dai Yang, G. V. Shivashankar, Caroline Uhler
163 [GO] 2021―Feb―16 Modelling safe protocols for reopening schools during the COVID-19 pandemic in France Laura Di Domenico, Giulia Pullano, Chiara E. Sabbatini, Pierre-Yves Boëlle, Vittoria Colizza
164 [GO] 2021―Feb―12 Impact of the COVID-19 nonpharmaceutical interventions on influenza and other respiratory viral infections in New Zealand Q. Sue Huang, Tim Wood, Lauren Jelley, Tineke Jennings, Sarah Jefferies, Karen Daniells, et al. (+44)
165 [GO] 2021―Feb―11 Methodological quality of COVID-19 clinical research Richard G. Jung, Pietro Di Santo, Cole Clifford, Graeme Prosperi-Porta, Stephanie Skanes, Annie Hung, et al. (+5)
166 [GO] 2021―Feb―11 A genome-wide CRISPR screen identifies host factors that regulate SARS-CoV-2 entry Yunkai Zhu, Fei Feng, Gaowei Hu, Yuyan Wang, Yin Yu, Yuanfei Zhu, et al. (+14)
167 [GO] 2021―Feb―11 Post-exposure protection of SARS-CoV-2 lethal infected K18-hACE2 transgenic mice by neutralizing human monoclonal antibody Ronit Rosenfeld, Tal Noy-Porat, Adva Mechaly, Efi Makdasi, Yinon Levy, Ron Alcalay, et al. (+16)
168 [GO] 2021―Feb―10 Potential health and economic impacts of dexamethasone treatment for patients with COVID-19 Ricardo Águas, Adam Mahdi, Rima Shretta, Peter Horby, Martin Landray, Lisa White
169 [GO] 2021―Feb―10 SARS-CoV-2 antibody prevalence in England following the first peak of the pandemic Helen Ward, Christina Atchison, Matthew Whitaker, Kylie E. C. Ainslie, Joshua Elliott, Lucy Okell, et al. (+8)
170 [GO] 2021―Feb―09 Quantifying population contact patterns in the United States during the COVID-19 pandemic Dennis M. Feehan, Ayesha S. Mahmud
171 [GO] 2021―Feb―09 Lasting antibody and T cell responses to SARS-CoV-2 in COVID-19 patients three months after infection Xiao-Lin Jiang, Guo-Lin Wang, Xiang-Na Zhao, Fei-Hu Yan, Lin Yao, Zeng-Qiang Kou, et al. (+17)
172 [GO] 2021―Feb―09 Evidence for SARS-CoV-2 related coronaviruses circulating in bats and pangolins in Southeast Asia Supaporn Wacharapluesadee, Chee Wah Tan, Patarapol Maneeorn, Prateep Duengkae, Feng Zhu, Yutthana Joyjinda, et al. (+18)
173 [GO] 2021―Feb―08 Rapid decline of neutralizing antibodies against SARS-CoV-2 among infected healthcare workers Stéphane Marot, Isabelle Malet, Valentin Leducq, Karen Zafilaza, Delphine Sterlin, Delphine Planas, et al. (+10)
174 [GO] 2021―Feb―08 SARS-CoV-2 D614G spike mutation increases entry efficiency with enhanced ACE2-binding affinity Seiya Ozono, Yanzhao Zhang, Hirotaka Ode, Kaori Sano, Toong Seng Tan, Kazuo Imai, et al. (+6)
175 [GO] 2021―Feb―08 Distinct mechanisms for TMPRSS2 expression explain organ-specific inhibition of SARS-CoV-2 infection by enzalutamide Fei Li, Ming Han, Pengfei Dai, Wei Xu, Juan He, Xiaoting Tao, et al. (+21)
176 [GO] 2021―Feb―08 Assessing the influence of climate on wintertime SARS-CoV-2 outbreaks Rachel E. Baker, Wenchang Yang, Gabriel A. Vecchi, C. Jessica E. Metcalf, Bryan T. Grenfell
177 [GO] 2021―Feb―05 Efficacy and tolerability of bevacizumab in patients with severe Covid-19 Jiaojiao Pang, Feng Xu, Gianmarco Aondio, Yu Li, Alberto Fumagalli, Ming Lu, et al. (+19)
178 [GO] 2021―Feb―05 Rapid electrochemical detection of coronavirus SARS-CoV-2 Thanyarat Chaibun, Jiratchaya Puenpa, Tatchanun Ngamdee, Nimaradee Boonapatcharoen, Pornpat Athamanolap, Anthony Peter O’Mullane, et al. (+4)
179 [GO] 2021―Feb―05 Structure and binding properties of Pangolin-CoV spike glycoprotein inform the evolution of SARS-CoV-2 Antoni G. Wrobel, Donald J. Benton, Pengqi Xu, Lesley J. Calder, Annabel Borg, Chloë Roustan, et al. (+4)
180 [GO] 2021―Feb―03 The natural history of symptomatic COVID-19 during the first wave in Catalonia Edward Burn, Cristian Tebé, Sergio Fernandez-Bertolin, Maria Aragon, Martina Recalde, Elena Roel, et al. (+3)
181 [GO] 2021―Feb―03 A single-dose mRNA vaccine provides a long-term protection for hACE2 transgenic mice from SARS-CoV-2 Qingrui Huang, Kai Ji, Siyu Tian, Fengze Wang, Baoying Huang, Zhou Tong, et al. (+6)
182 [GO] 2021―Feb―02 A multiplex chemiluminescent immunoassay for serological profiling of COVID-19-positive symptomatic and asymptomatic patients Allison N. Grossberg, Lilia A. Koza, Aurélie Ledreux, Chad Prusmack, Hari Krishnan Krishnamurthy, Vasanth Jayaraman, et al. (+2)
183 [GO] 2021―Feb―02 Structure of papain-like protease from SARS-CoV-2 and its complexes with non-covalent inhibitors Jerzy Osipiuk, Saara-Anne Azizi, Steve Dvorkin, Michael Endres, Robert Jedrzejczak, Krysten A. Jones, et al. (+15)
184 [GO] 2021―Feb―02 Author Correction: Genetic architecture of host proteins involved in SARS-CoV-2 infection Maik Pietzner, Eleanor Wheeler, Julia Carrasco-Zanini, Johannes Raffler, Nicola D. Kerrison, Erin Oerton, et al. (+12)
185 [GO] 2021―Feb―01 Addendum: Early triage of critically ill COVID-19 patients using deep learning Wenhua Liang, Jianhua Yao, Ailan Chen, Qingquan Lv, Mark Zanin, Jun Liu, et al. (+27)
186 [GO] 2021―Jan―28 A small molecule compound with an indole moiety inhibits the main protease of SARS-CoV-2 and blocks virus replication Shin-ichiro Hattori, Nobuyo Higashi-Kuwata, Hironori Hayashi, Srinivasa Rao Allu, Jakka Raghavaiah, Haydar Bulut, et al. (+17)
187 [GO] 2021―Jan―28 Genomic epidemiology of the early stages of the SARS-CoV-2 outbreak in Russia Andrey B. Komissarov, Ksenia R. Safina, Sofya K. Garushyants, Artem V. Fadeev, Mariia V. Sergeeva, Anna A. Ivanova, et al. (+8)
188 [GO] 2021―Jan―27 Integrating deep learning CT-scan model, biological and clinical variables to predict severity of COVID-19 patients Nathalie Lassau, Samy Ammari, Emilie Chouzenoux, Hugo Gortais, Paul Herent, Matthieu Devilder, et al. (+42)
189 [GO] 2021―Jan―27 Cryo-EM structures of the SARS-CoV-2 endoribonuclease Nsp15 reveal insight into nuclease specificity and dynamics Monica C. Pillon, Meredith N. Frazier, Lucas B. Dillard, Jason G. Williams, Seda Kocaman, Juno M. Krahn, et al. (+10)
190 [GO] 2021―Jan―22 A COVID-19 vaccine candidate using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responses Tiong Kit Tan, Pramila Rijal, Rolle Rahikainen, Anthony H. Keeble, Lisa Schimanski, Saira Hussain, et al. (+48)
191 [GO] 2021―Jan―22 SARS-CoV-2 induces robust germinal center CD4 T follicular helper cell responses in rhesus macaques Yashavanth Shaan Lakshmanappa, Sonny R. Elizaldi, Jamin W. Roh, Brian A. Schmidt, Timothy D. Carroll, Kourtney D. Weaver, et al. (+27)
192 [GO] 2021―Jan―21 The SARS-CoV-2 nucleocapsid phosphoprotein forms mutually exclusive condensates with RNA and the membrane-associated M protein Shan Lu, Qiaozhen Ye, Digvijay Singh, Yong Cao, Jolene K. Diedrich, John R. Yates, et al. (+3)
193 [GO] 2021―Jan―20 Molecular determinants and mechanism for antibody cocktail preventing SARS-CoV-2 escape Zhiqiang Ku, Xuping Xie, Edgar Davidson, Xiaohua Ye, Hang Su, Vineet D. Menachery, et al. (+15)
194 [GO] 2021―Jan―20 The complex structure of GRL0617 and SARS-CoV-2 PLpro reveals a hot spot for antiviral drug discovery Ziyang Fu, Bin Huang, Jinle Tang, Shuyan Liu, Ming Liu, Yuxin Ye, et al. (+10)
195 [GO] 2021―Jan―19 Genomic epidemiology of SARS-CoV-2 reveals multiple lineages and early spread of SARS-CoV-2 infections in Lombardy, Italy Claudia Alteri, Valeria Cento, Antonio Piralla, Valentino Costabile, Monica Tallarita, Luna Colagrossi, et al. (+12)
196 [GO] 2021―Jan―18 Mathematical model of COVID-19 intervention scenarios for São Paulo-Brazil Osmar Pinto Neto, Deanna M. Kennedy, José Clark Reis, Yiyu Wang, Ana Carolina Brisola Brizzi, Gustavo José Zambrano, et al. (+6)
197 [GO] 2021―Jan―15 The challenges of containing SARS-CoV-2 via test-trace-and-isolate Sebastian Contreras, Jonas Dehning, Matthias Loidolt, Johannes Zierenberg, F. Paul Spitzner, Jorge H. Urrea-Quintero, et al. (+4)
198 [GO] 2021―Jan―14 SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice Jing-Hui Tian, Nita Patel, Robert Haupt, Haixia Zhou, Stuart Weston, Holly Hammond, et al. (+24)
199 [GO] 2021―Jan―12 Mathematical modeling of COVID-19 in 14.8 million individuals in Bahia, Brazil Juliane F. Oliveira, Daniel C. P. Jorge, Rafael V. Veiga, Moreno S. Rodrigues, Matheus F. Torquato, Nivea B. da Silva, et al. (+11)
200 [GO] 2021―Jan―12 Estimating internationally imported cases during the early COVID-19 pandemic Tigist F. Menkir, Taylor Chin, James A. Hay, Erik D. Surface, Pablo M. De Salazar, Caroline O. Buckee, et al. (+7)
201 [GO] 2021―Jan―12 Mechanism of SARS-CoV-2 polymerase stalling by remdesivir Goran Kokic, Hauke S. Hillen, Dimitry Tegunov, Christian Dienemann, Florian Seitz, Jana Schmitzova, et al. (+4)
202 [GO] 2021―Jan―12 Capsid-like particles decorated with the SARS-CoV-2 receptor-binding domain elicit strong virus neutralization activity Cyrielle Fougeroux, Louise Goksøyr, Manja Idorn, Vladislav Soroka, Sebenzile K. Myeni, Robert Dagil, et al. (+41)
203 [GO] 2021―Jan―12 A therapeutic neutralizing antibody targeting receptor binding domain of SARS-CoV-2 spike protein Cheolmin Kim, Dong-Kyun Ryu, Jihun Lee, Young-Il Kim, Ji-Min Seo, Yeon-Gil Kim, et al. (+39)
204 [GO] 2021―Jan―11 Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19) Jeroen J. A. van Kampen, David A. M. C. van de Vijver, Pieter L. A. Fraaij, Bart L. Haagmans, Mart M. Lamers, Nisreen Okba, et al. (+19)
205 [GO] 2021―Jan―11 Bidirectional contact tracing could dramatically improve COVID-19 control William J. Bradshaw, Ethan C. Alley, Jonathan H. Huggins, Alun L. Lloyd, Kevin M. Esvelt
206 [GO] 2021―Jan―11 Isolation of MERS-related coronavirus from lesser bamboo bats that uses DPP4 and infects human-DPP4-transgenic mice Susanna K. P. Lau, Rachel Y. Y. Fan, Longchao Zhu, Kenneth S. M. Li, Antonio C. P. Wong, Hayes K. H. Luk, et al. (+11)
207 [GO] 2021―Jan―11 Development and structural basis of a two-MAb cocktail for treating SARS-CoV-2 infections Chao Zhang, Yifan Wang, Yuanfei Zhu, Caixuan Liu, Chenjian Gu, Shiqi Xu, et al. (+24)
208 [GO] 2021―Jan―11 Stabilizing the closed SARS-CoV-2 spike trimer Jarek Juraszek, Lucy Rutten, Sven Blokland, Pascale Bouchier, Richard Voorzaat, Tina Ritschel, et al. (+3)
209 [GO] 2021―Jan―11 Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry Jiwan Ge, Ruoke Wang, Bin Ju, Qi Zhang, Jing Sun, Peng Chen, et al. (+15)
210 [GO] 2021―Jan―11 Multistage and transmission-blocking targeted antimalarials discovered from the open-source MMV Pandemic Response Box Janette Reader, Mariëtte E. van der Watt, Dale Taylor, Claire Le Manach, Nimisha Mittal, Sabine Ottilie, et al. (+27)
211 [GO] 2021―Jan―08 Host and viral determinants for efficient SARS-CoV-2 infection of the human lung Hin Chu, Bingjie Hu, Xiner Huang, Yue Chai, Dongyan Zhou, Yixin Wang, et al. (+23)
212 [GO] 2021―Jan―07 Optimal COVID-19 quarantine and testing strategies Chad R. Wells, Jeffrey P. Townsend, Abhishek Pandey, Seyed M. Moghadas, Gary Krieger, Burton Singer, et al. (+3)
213 [GO] 2021―Jan―04 Analysis of SARS-CoV-2 antibodies in COVID-19 convalescent blood using a coronavirus antigen microarray Rafael R. de Assis, Aarti Jain, Rie Nakajima, Algis Jasinskas, Jiin Felgner, Joshua M. Obiero, et al. (+21)
214 [GO] 2021―Jan―04 Psychological characteristics associated with COVID-19 vaccine hesitancy and resistance in Ireland and the United Kingdom Jamie Murphy, Frédérique Vallières, Richard P. Bentall, Mark Shevlin, Orla McBride, Todd K. Hartman, et al. (+9)
215 [GO] 2021―Jan―04 The aging transcriptome and cellular landscape of the human lung in relation to SARS-CoV-2 Ryan D. Chow, Medha Majety, Sidi Chen
216 [GO] 2021―Jan―04 Dose-dependent response to infection with SARS-CoV-2 in the ferret model and evidence of protective immunity Kathryn A. Ryan, Kevin R. Bewley, Susan A. Fotheringham, Gillian S. Slack, Phillip Brown, Yper Hall, et al. (+49)
217 [GO] 2021―Jan―04 Neutralizing antibody titres in SARS-CoV-2 infections Eric H. Y. Lau, Owen T. Y. Tsang, David S. C. Hui, Mike Y. W. Kwan, Wai-hung Chan, Susan S. Chiu, et al. (+7)
218 [GO] 2021―Jan―04 Standardization of ELISA protocols for serosurveys of the SARS-CoV-2 pandemic using clinical and at-home blood sampling Carleen Klumpp-Thomas, Heather Kalish, Matthew Drew, Sally Hunsberger, Kelly Snead, Michael P. Fay, et al. (+15)
219 [GO] 2020―Dec―16 A single dose of recombinant VSV-∆G-spike vaccine provides protection against SARS-CoV-2 challenge Yfat Yahalom-Ronen, Hadas Tamir, Sharon Melamed, Boaz Politi, Ohad Shifman, Hagit Achdout, et al. (+30)
220 [GO] 2020―Dec―16 Genetic architecture of host proteins involved in SARS-CoV-2 infection Maik Pietzner, Eleanor Wheeler, Julia Carrasco-Zanini, Johannes Raffler, Nicola D. Kerrison, Erin Oerton, et al. (+12)
221 [GO] 2020―Dec―14 Treatment of COVID-19 with remdesivir in the absence of humoral immunity: a case report Matthew S. Buckland, James B. Galloway, Caoimhe Nic Fhogartaigh, Luke Meredith, Nicholas M. Provine, Stuart Bloor, et al. (+43)
222 [GO] 2020―Dec―11 Genomic epidemiology reveals transmission patterns and dynamics of SARS-CoV-2 in Aotearoa New Zealand Jemma L. Geoghegan, Xiaoyun Ren, Matthew Storey, James Hadfield, Lauren Jelley, Sarah Jefferies, et al. (+15)
223 [GO] 2020―Dec―09 Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission Hannah Peckham, Nina M. de Gruijter, Charles Raine, Anna Radziszewska, Coziana Ciurtin, Lucy R. Wedderburn, et al. (+3)
224 [GO] 2020―Dec―09 Analytical validity of nanopore sequencing for rapid SARS-CoV-2 genome analysis Rowena A. Bull, Thiruni N. Adikari, James M. Ferguson, Jillian M. Hammond, Igor Stevanovski, Alicia G. Beukers, et al. (+11)
225 [GO] 2020―Dec―09 Temporal and spatial heterogeneity of host response to SARS-CoV-2 pulmonary infection Niyati Desai, Azfar Neyaz, Annamaria Szabolcs, Angela R. Shih, Jonathan H. Chen, Vishal Thapar, et al. (+27)
226 [GO] 2020―Dec―08 Building resilient Arctic science amid the COVID-19 pandemic Andrey N. Petrov, Larry D. Hinzman, Lars Kullerud, Tatiana S. Degai, Liisa Holmberg, Allen Pope, Alona Yefimenko
227 [GO] 2020―Dec―07 Pandemic Vibrio cholerae shuts down site-specific recombination to retain an interbacterial defence mechanism Francis J. Santoriello, Lina Michel, Daniel Unterweger, Stefan Pukatzki
228 [GO] 2020―Dec―04 Longitudinal symptom dynamics of COVID-19 infection Barak Mizrahi, Smadar Shilo, Hagai Rossman, Nir Kalkstein, Karni Marcus, Yael Barer, et al. (+6)
229 [GO] 2020―Dec―04 Evidence of exposure to SARS-CoV-2 in cats and dogs from households in Italy E. I. Patterson, G. Elia, A. Grassi, A. Giordano, C. Desario, M. Medardo, et al. (+18)
230 [GO] 2020―Dec―03 State-level tracking of COVID-19 in the United States H. Juliette T. Unwin, Swapnil Mishra, Valerie C. Bradley, Axel Gandy, Thomas A. Mellan, Helen Coupland, et al. (+47)
231 [GO] 2020―Dec―03 Establishing a mass spectrometry-based system for rapid detection of SARS-CoV-2 in large clinical sample cohorts Karina Helena Morais Cardozo, Adriana Lebkuchen, Guilherme Gonçalves Okai, Rodrigo Andrade Schuch, Luciana Godoy Viana, Aline Nogueira Olive, et al. (+5)
232 [GO] 2020―Dec―02 Author Correction: Near-real-time monitoring of global CO2 emissions reveals the effects of the COVID-19 pandemic Zhu Liu, Philippe Ciais, Zhu Deng, Ruixue Lei, Steven J. Davis, Sha Feng, et al. (+38)
233 [GO] 2020―Dec―01 Winnie Byanyima answers questions about the impact of the COVID-19 pandemic on the UNAIDS’ Fast Track targets for 2020
234 [GO] 2020―Nov―30 Lethality of SARS-CoV-2 infection in K18 human angiotensin-converting enzyme 2 transgenic mice Fatai S. Oladunni, Jun-Gyu Park, Paula A. Pino, Olga Gonzalez, Anwari Akhter, Anna Allué-Guardia, et al. (+36)
235 [GO] 2020―Nov―30 Development of a multi-antigenic SARS-CoV-2 vaccine candidate using a synthetic poxvirus platform Flavia Chiuppesi, Marcela d’Alincourt Salazar, Heidi Contreras, Vu H. Nguyen, Joy Martinez, Yoonsuh Park, et al. (+14)
236 [GO] 2020―Nov―27 Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19 Kening Li, Bin Huang, Min Wu, Aifang Zhong, Lu Li, Yun Cai, et al. (+14)
237 [GO] 2020―Nov―27 Cellular events of acute, resolving or progressive COVID-19 in SARS-CoV-2 infected non-human primates M. D. Fahlberg, R. V. Blair, L. A. Doyle-Meyers, C. C. Midkiff, G. Zenere, K. E. Russell-Lodrigue, et al. (+13)
238 [GO] 2020―Nov―27 SARS-CoV-2 genomic and subgenomic RNAs in diagnostic samples are not an indicator of active replication Soren Alexandersen, Anthony Chamings, Tarka Raj Bhatta
239 [GO] 2020―Nov―27 Nucleocapsid protein of SARS-CoV-2 phase separates into RNA-rich polymerase-containing condensates Adriana Savastano, Alain Ibáñez de Opakua, Marija Rankovic, Markus Zweckstetter
240 [GO] 2020―Nov―26 SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity Lizhou Zhang, Cody B. Jackson, Huihui Mou, Amrita Ojha, Haiyong Peng, Brian D. Quinlan, et al. (+9)
241 [GO] 2020―Nov―25 No evidence for increased transmissibility from recurrent mutations in SARS-CoV-2 Lucy van Dorp, Damien Richard, Cedric C. S. Tan, Liam P. Shaw, Mislav Acman, François Balloux
242 [GO] 2020―Nov―20 Streamlined inactivation, amplification, and Cas13-based detection of SARS-CoV-2 Jon Arizti-Sanz, Catherine A. Freije, Alexandra C. Stanton, Brittany A. Petros, Chloe K. Boehm, Sameed Siddiqui, et al. (+17)
243 [GO] 2020―Nov―20 Post-lockdown SARS-CoV-2 nucleic acid screening in nearly ten million residents of Wuhan, China Shiyi Cao, Yong Gan, Chao Wang, Max Bachmann, Shanbo Wei, Jie Gong, et al. (+13)
244 [GO] 2020―Nov―18 Crystallographic structure of wild-type SARS-CoV-2 main protease acyl-enzyme intermediate with physiological C-terminal autoprocessing site Jaeyong Lee, Liam J. Worrall, Marija Vuckovic, Federico I. Rosell, Francesco Gentile, Anh-Tien Ton, et al. (+5)
245 [GO] 2020―Nov―18 Architecture of a SARS-CoV-2 mini replication and transcription complex Liming Yan, Ying Zhang, Ji Ge, Litao Zheng, Yan Gao, Tao Wang, et al. (+7)
246 [GO] 2020―Nov―18 SARS-CoV-2 structure and replication characterized by in situ cryo-electron tomography Steffen Klein, Mirko Cortese, Sophie L. Winter, Moritz Wachsmuth-Melm, Christopher J. Neufeldt, Berati Cerikan, et al. (+4)
247 [GO] 2020―Nov―17 Immune suppression in the early stage of COVID-19 disease Wenmin Tian, Nan Zhang, Ronghua Jin, Yingmei Feng, Siyuan Wang, Shuaixin Gao, et al. (+7)
248 [GO] 2020―Nov―17 Upper airway gene expression reveals suppressed immune responses to SARS-CoV-2 compared with other respiratory viruses Eran Mick, Jack Kamm, Angela Oliveira Pisco, Kalani Ratnasiri, Jennifer M. Babik, Gloria Castañeda, et al. (+17)
249 [GO] 2020―Nov―17 STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters Robbert Boudewijns, Hendrik Jan Thibaut, Suzanne J. F. Kaptein, Rong Li, Valentijn Vergote, Laura Seldeslachts, et al. (+45)
250 [GO] 2020―Nov―17 Infection fatality rate of SARS-CoV2 in a super-spreading event in Germany Hendrik Streeck, Bianca Schulte, Beate M. Kümmerer, Enrico Richter, Tobias Höller, Christine Fuhrmann, et al. (+16)
251 [GO] 2020―Nov―13 Associations between blood type and COVID-19 infection, intubation, and death Michael Zietz, Jason Zucker, Nicholas P. Tatonetti
252 [GO] 2020―Nov―13 Characterization of neutralizing antibody with prophylactic and therapeutic efficacy against SARS-CoV-2 in rhesus monkeys Shuang Wang, Yun Peng, Rongjuan Wang, Shasha Jiao, Min Wang, Weijin Huang, et al. (+20)
253 [GO] 2020―Nov―12 A framework for research linking weather, climate and COVID-19 Benjamin F. Zaitchik, Neville Sweijd, Joy Shumake-Guillemot, Andy Morse, Chris Gordon, Aileen Marty, et al. (+9)
254 [GO] 2020―Nov―12 Collider bias undermines our understanding of COVID-19 disease risk and severity Gareth J. Griffith, Tim T. Morris, Matthew J. Tudball, Annie Herbert, Giulia Mancano, Lindsey Pike, et al. (+8)
255 [GO] 2020―Nov―12 Low SARS-CoV-2 seroprevalence in blood donors in the early COVID-19 epidemic in the Netherlands Ed Slot, Boris M. Hogema, Chantal B. E. M. Reusken, Johan H. Reimerink, Michel Molier, Jan H. M. Karregat, et al. (+4)
256 [GO] 2020―Nov―11 Immune responses to SARS-CoV-2 in three children of parents with symptomatic COVID-19 Shidan Tosif, Melanie R. Neeland, Philip Sutton, Paul V. Licciardi, Sohinee Sarkar, Kevin J. Selva, et al. (+24)
257 [GO] 2020―Nov―11 Modelling transmission and control of the COVID-19 pandemic in Australia Sheryl L. Chang, Nathan Harding, Cameron Zachreson, Oliver M. Cliff, Mikhail Prokopenko
258 [GO] 2020―Nov―04 Selection, biophysical and structural analysis of synthetic nanobodies that effectively neutralize SARS-CoV-2 Tânia F. Custódio, Hrishikesh Das, Daniel J. Sheward, Leo Hanke, Samuel Pazicky, Joanna Pieprzyk, et al. (+13)
259 [GO] 2020―Nov―03 Revealing fine-scale spatiotemporal differences in SARS-CoV-2 introduction and spread Gage K. Moreno, Katarina M. Braun, Kasen K. Riemersma, Michael A. Martin, Peter J. Halfmann, Chelsea M. Crooks, et al. (+18)
260 [GO] 2020―Nov―02 Full genome viral sequences inform patterns of SARS-CoV-2 spread into and within Israel Danielle Miller, Michael A. Martin, Noam Harel, Omer Tirosh, Talia Kustin, Moran Meir, et al. (+13)
261 [GO] 2020―Oct―30 Genomic surveillance of COVID-19 cases in Beijing Pengcheng Du, Nan Ding, Jiarui Li, Fujie Zhang, Qi Wang, Zhihai Chen, et al. (+22)
262 [GO] 2020―Oct―30 SARS-CoV-2 viral load is associated with increased disease severity and mortality Jesse Fajnzylber, James Regan, Kendyll Coxen, Heather Corry, Colline Wong, Alexandra Rosenthal, et al. (+24)
263 [GO] 2020―Oct―27 Disease burden and clinical severity of the first pandemic wave of COVID-19 in Wuhan, China Juan Yang, Xinhua Chen, Xiaowei Deng, Zhiyuan Chen, Hui Gong, Han Yan, et al. (+6)
264 [GO] 2020―Oct―27 Structural basis for potent neutralization of SARS-CoV-2 and role of antibody affinity maturation Nicholas K. Hurlburt, Emilie Seydoux, Yu-Hsin Wan, Venkata Viswanadh Edara, Andrew B. Stuart, Junli Feng, et al. (+4)
265 [GO] 2020―Oct―22 The seventh pandemic of cholera in Europe revisited by microbial genomics Mihaela Oprea, Elisabeth Njamkepo, Daniela Cristea, Anna Zhukova, Clifford G. Clark, Anatoly N. Kravetz, et al. (+8)
266 [GO] 2020―Oct―21 Antibody-mediated disruption of the SARS-CoV-2 spike glycoprotein Antoni G. Wrobel, Donald J. Benton, Saira Hussain, Ruth Harvey, Stephen R. Martin, Chloë Roustan, et al. (+3)
267 [GO] 2020―Oct―21 Author Correction: SARS-CoV2-mediated suppression of NRF2-signaling reveals potent antiviral and anti-inflammatory activity of 4-octyl-itaconate and dimethyl fumarate David Olagnier, Ensieh Farahani, Jacob Thyrsted, Julia Blay-Cadanet, Angela Herengt, Manja Idorn, et al. (+32)
268 [GO] 2020―Oct―20 A pragmatic randomized controlled trial reports lack of efficacy of hydroxychloroquine on coronavirus disease 2019 viral kinetics Magnus Nakrem Lyngbakken, Jan-Erik Berdal, Arne Eskesen, Dag Kvale, Inge Christoffer Olsen, Corina Silvia Rueegg, et al. (+5)
269 [GO] 2020―Oct―20 Author Correction: Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication Wayne Vuong, Muhammad Bashir Khan, Conrad Fischer, Elena Arutyunova, Tess Lamer, Justin Shields, et al. (+8)
270 [GO] 2020―Oct―16 Whole blood immunophenotyping uncovers immature neutrophil-to-VD2 T-cell ratio as an early marker for severe COVID-19 Guillaume Carissimo, Weili Xu, Immanuel Kwok, Mohammad Yazid Abdad, Yi-Hao Chan, Siew-Wai Fong, et al. (+18)
271 [GO] 2020―Oct―15 A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19 Xuping Xie, Antonio E. Muruato, Xianwen Zhang, Kumari G. Lokugamage, Camila R. Fontes-Garfias, Jing Zou, et al. (+9)
272 [GO] 2020―Oct―15 Synthesis and systematic review of reported neonatal SARS-CoV-2 infections Roberto Raschetti, Alexandre J. Vivanti, Christelle Vauloup-Fellous, Barbara Loi, Alexandra Benachi, Daniele De Luca
273 [GO] 2020―Oct―14 Near-real-time monitoring of global CO2 emissions reveals the effects of the COVID-19 pandemic Zhu Liu, Philippe Ciais, Zhu Deng, Ruixue Lei, Steven J. Davis, Sha Feng, et al. (+38)
274 [GO] 2020―Oct―14 Smell and taste changes are early indicators of the COVID-19 pandemic and political decision effectiveness Denis Pierron, Veronica Pereda-Loth, Marylou Mantel, Maëlle Moranges, Emmanuelle Bignon, Omar Alva, et al. (+18)
275 [GO] 2020―Oct―12 Type 2 and interferon inflammation regulate SARS-CoV-2 entry factor expression in the airway epithelium Satria P. Sajuthi, Peter DeFord, Yingchun Li, Nathan D. Jackson, Michael T. Montgomery, Jamie L. Everman, et al. (+22)
276 [GO] 2020―Oct―12 Analysis of SARS-CoV-2 vertical transmission during pregnancy Claudio Fenizia, Mara Biasin, Irene Cetin, Patrizia Vergani, Davide Mileto, Arsenio Spinillo, et al. (+10)
277 [GO] 2020―Oct―09 A population-based cohort study of socio-demographic risk factors for COVID-19 deaths in Sweden Sven Drefahl, Matthew Wallace, Eleonora Mussino, Siddartha Aradhya, Martin Kolk, Maria Brandén, et al. (+2)
278 [GO] 2020―Oct―09 Development and evaluation of an artificial intelligence system for COVID-19 diagnosis Cheng Jin, Weixiang Chen, Yukun Cao, Zhanwei Xu, Zimeng Tan, Xin Zhang, et al. (+5)
279 [GO] 2020―Oct―09 A network model of Italy shows that intermittent regional strategies can alleviate the COVID-19 epidemic Fabio Della Rossa, Davide Salzano, Anna Di Meglio, Francesco De Lellis, Marco Coraggio, Carmela Calabrese, et al. (+7)
280 [GO] 2020―Oct―09 Accommodating individual travel history and unsampled diversity in Bayesian phylogeographic inference of SARS-CoV-2 Philippe Lemey, Samuel L. Hong, Verity Hill, Guy Baele, Chiara Poletto, Vittoria Colizza, et al. (+7)
281 [GO] 2020―Oct―08 Two distinct immunopathological profiles in autopsy lungs of COVID-19 Ronny Nienhold, Yari Ciani, Viktor H. Koelzer, Alexandar Tzankov, Jasmin D. Haslbauer, Thomas Menter, et al. (+14)
282 [GO] 2020―Oct―08 SARS-CoV-2 exposure, symptoms and seroprevalence in healthcare workers in Sweden Ann-Sofie Rudberg, Sebastian Havervall, Anna Månberg, August Jernbom Falk, Katherina Aguilera, Henry Ng, et al. (+18)
283 [GO] 2020―Oct―07 Many small steps towards a COVID-19 drug Daniel A. Erlanson
284 [GO] 2020―Oct―07 Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease Alice Douangamath, Daren Fearon, Paul Gehrtz, Tobias Krojer, Petra Lukacik, C. David Owen, et al. (+28)
285 [GO] 2020―Oct―06 Machine learning based early warning system enables accurate mortality risk prediction for COVID-19 Yue Gao, Guang-Yao Cai, Wei Fang, Hua-Yi Li, Si-Yuan Wang, Lingxi Chen, et al. (+26)
286 [GO] 2020―Oct―06 Deep phenotyping of 34,128 adult patients hospitalised with COVID-19 in an international network study Edward Burn, Seng Chan You, Anthony G. Sena, Kristin Kostka, Hamed Abedtash, Maria Tereza F. Abrahão, et al. (+63)
287 [GO] 2020―Oct―06 Changing travel patterns in China during the early stages of the COVID-19 pandemic Hamish Gibbs, Yang Liu, Carl A. B. Pearson, Christopher I. Jarvis, Chris Grundy, Billy J. Quilty, et al. (+2)
288 [GO] 2020―Oct―06 Inference of person-to-person transmission of COVID-19 reveals hidden super-spreading events during the early outbreak phase Liang Wang, Xavier Didelot, Jing Yang, Gary Wong, Yi Shi, Wenjun Liu, et al. (+2)
289 [GO] 2020―Oct―02 Early prediction of disease progression in COVID-19 pneumonia patients with chest CT and clinical characteristics Zhichao Feng, Qizhi Yu, Shanhu Yao, Lei Luo, Wenming Zhou, Xiaowen Mao, et al. (+20)
290 [GO] 2020―Oct―02 SARS-CoV2-mediated suppression of NRF2-signaling reveals potent antiviral and anti-inflammatory activity of 4-octyl-itaconate and dimethyl fumarate David Olagnier, Ensieh Farahani, Jacob Thyrsted, Julia Blay-Cadanet, Angela Herengt, Manja Idorn, et al. (+32)
291 [GO] 2020―Sep―30 The use of mobile phone data to inform analysis of COVID-19 pandemic epidemiology Kyra H. Grantz, Hannah R. Meredith, Derek A. T. Cummings, C. Jessica E. Metcalf, Bryan T. Grenfell, John R. Giles, et al. (+6)
292 [GO] 2020―Sep―30 A vision for actionable science in a pandemic
293 [GO] 2020―Sep―28 Modeling lung perfusion abnormalities to explain early COVID-19 hypoxemia Jacob Herrmann, Vitor Mori, Jason H. T. Bates, Béla Suki
294 [GO] 2020―Sep―23 Massive and rapid COVID-19 testing is feasible by extraction-free SARS-CoV-2 RT-PCR Ioanna Smyrlaki, Martin Ekman, Antonio Lentini, Nuno Rufino de Sousa, Natali Papanicolaou, Martin Vondracek, et al. (+7)
295 [GO] 2020―Sep―18 Ultrasensitive and visual detection of SARS-CoV-2 using all-in-one dual CRISPR-Cas12a assay Xiong Ding, Kun Yin, Ziyue Li, Rajesh V. Lalla, Enrique Ballesteros, Maroun M. Sfeir, Changchun Liu
296 [GO] 2020―Sep―17 A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity Angkana T. Huang, Bernardo Garcia-Carreras, Matt D. T. Hitchings, Bingyi Yang, Leah C. Katzelnick, Susan M. Rattigan, et al. (+11)
297 [GO] 2020―Sep―17 Author Correction: A role for Biofoundries in rapid development and validation of automated SARS-CoV-2 clinical diagnostics Michael A. Crone, Miles Priestman, Marta Ciechonska, Kirsten Jensen, David J. Sharp, Arthi Anand, et al. (+3)
298 [GO] 2020―Sep―17 Rapid incorporation of Favipiravir by the fast and permissive viral RNA polymerase complex results in SARS-CoV-2 lethal mutagenesis Ashleigh Shannon, Barbara Selisko, Nhung-Thi-Tuyet Le, Johanna Huchting, Franck Touret, Géraldine Piorkowski, et al. (+7)
299 [GO] 2020―Sep―17 SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood Dianna L. Ng, Gregory M. Goldgof, Brian R. Shy, Andrew G. Levine, Joanna Balcerek, Sagar P. Bapat, et al. (+43)
300 [GO] 2020―Sep―16 Cryo-EM structure of coronavirus-HKU1 haemagglutinin esterase reveals architectural changes arising from prolonged circulation in humans Daniel L. Hurdiss, Ieva Drulyte, Yifei Lang, Tatiana M. Shamorkina, Matti F. Pronker, Frank J. M. van Kuppeveld, et al. (+2)
301 [GO] 2020―Sep―16 Reductions in commuting mobility correlate with geographic differences in SARS-CoV-2 prevalence in New York City Stephen M. Kissler, Nishant Kishore, Malavika Prabhu, Dena Goffman, Yaakov Beilin, Ruth Landau, et al. (+11)
302 [GO] 2020―Sep―11 Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor Jinsung Yang, Simon J. L. Petitjean, Melanie Koehler, Qingrong Zhang, Andra C. Dumitru, Wenzhang Chen, et al. (+4)
303 [GO] 2020―Sep―10 Humanized single domain antibodies neutralize SARS-CoV-2 by targeting the spike receptor binding domain Xiaojing Chi, Xiuying Liu, Conghui Wang, Xinhui Zhang, Xiang Li, Jianhua Hou, et al. (+4)
304 [GO] 2020―Sep―10 A role for Biofoundries in rapid development and validation of automated SARS-CoV-2 clinical diagnostics Michael A. Crone, Miles Priestman, Marta Ciechonska, Kirsten Jensen, David J. Sharp, Arthi Anand, et al. (+3)
305 [GO] 2020―Sep―10 Substantial underestimation of SARS-CoV-2 infection in the United States Sean L. Wu, Andrew N. Mertens, Yoshika S. Crider, Anna Nguyen, Nolan N. Pokpongkiat, Stephanie Djajadi, et al. (+7)
306 [GO] 2020―Sep―07 Developing a COVID-19 mortality risk prediction model when individual-level data are not available Noam Barda, Dan Riesel, Amichay Akriv, Joseph Levy, Uriah Finkel, Gal Yona, et al. (+9)
307 [GO] 2020―Sep―04 An alpaca nanobody neutralizes SARS-CoV-2 by blocking receptor interaction Leo Hanke, Laura Vidakovics Perez, Daniel J. Sheward, Hrishikesh Das, Tim Schulte, Ainhoa Moliner-Morro, et al. (+6)
308 [GO] 2020―Sep―04 Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease Lifeng Fu, Fei Ye, Yong Feng, Feng Yu, Qisheng Wang, Yan Wu, et al. (+10)
309 [GO] 2020―Sep―02 Ocular conjunctival inoculation of SARS-CoV-2 can cause mild COVID-19 in rhesus macaques Wei Deng, Linlin Bao, Hong Gao, Zhiguang Xiang, Yajin Qu, Zhiqi Song, et al. (+20)
310 [GO] 2020―Sep―01 Tracking the COVID-19 pandemic in Australia using genomics Torsten Seemann, Courtney R. Lane, Norelle L. Sherry, Sebastian Duchene, Anders Gonçalves da Silva, Leon Caly, et al. (+15)
311 [GO] 2020―Sep―01 Serological identification of SARS-CoV-2 infections among children visiting a hospital during the initial Seattle outbreak Adam S. Dingens, Katharine H. D. Crawford, Amanda Adler, Sarah L. Steele, Kirsten Lacombe, Rachel Eguia, et al. (+14)
312 [GO] 2020―Aug―27 Misconceptions about weather and seasonality must not misguide COVID-19 response Colin J. Carlson, Ana C. R. Gomez, Shweta Bansal, Sadie J. Ryan
313 [GO] 2020―Aug―27 Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication Wayne Vuong, Muhammad Bashir Khan, Conrad Fischer, Elena Arutyunova, Tess Lamer, Justin Shields, et al. (+8)
314 [GO] 2020―Aug―27 A panel of human neutralizing mAbs targeting SARS-CoV-2 spike at multiple epitopes Tal Noy-Porat, Efi Makdasi, Ron Alcalay, Adva Mechaly, Yinon Levy, Adi Bercovich-Kinori, et al. (+17)
315 [GO] 2020―Aug―26 Emerging preclinical evidence does not support broad use of hydroxychloroquine in COVID-19 patients S. G. P. Funnell, W. E. Dowling, C. Muñoz-Fontela, P.-S. Gsell, D. E. Ingber, G. A. Hamilton, et al. (+12)
316 [GO] 2020―Aug―26 The geography of COVID-19 spread in Italy and implications for the relaxation of confinement measures Enrico Bertuzzo, Lorenzo Mari, Damiano Pasetto, Stefano Miccoli, Renato Casagrandi, Marino Gatto, Andrea Rinaldo
317 [GO] 2020―Aug―25 Origin and cross-species transmission of bat coronaviruses in China Alice Latinne, Ben Hu, Kevin J. Olival, Guangjian Zhu, Libiao Zhang, Hongying Li, et al. (+9)
318 [GO] 2020―Aug―25 A broad-spectrum virus- and host-targeting peptide against respiratory viruses including influenza virus and SARS-CoV-2 Hanjun Zhao, Kelvin K. W. To, Kong-Hung Sze, Timothy Tin-Mong Yung, Mingjie Bian, Hoiyan Lam, et al. (+4)
319 [GO] 2020―Aug―21 An adenovirus-vectored COVID-19 vaccine confers protection from SARS-COV-2 challenge in rhesus macaques Liqiang Feng, Qian Wang, Chao Shan, Chenchen Yang, Ying Feng, Jia Wu, et al. (+25)
320 [GO] 2020―Aug―21 A cross-reactive human IgA monoclonal antibody blocks SARS-CoV-2 spike-ACE2 interaction Monir Ejemel, Qi Li, Shurong Hou, Zachary A. Schiller, Julia A. Tree, Aaron Wallace, et al. (+19)
321 [GO] 2020―Aug―14 Artificial intelligence for the detection of COVID-19 pneumonia on chest CT using multinational datasets Stephanie A. Harmon, Thomas H. Sanford, Sheng Xu, Evrim B. Turkbey, Holger Roth, Ziyue Xu, et al. (+33)
322 [GO] 2020―Aug―14 A single dose of an adenovirus-vectored vaccine provides protection against SARS-CoV-2 challenge Shipo Wu, Gongxun Zhong, Jun Zhang, Lei Shuai, Zhe Zhang, Zhiyuan Wen, et al. (+19)
323 [GO] 2020―Aug―13 A high-throughput neutralizing antibody assay for COVID-19 diagnosis and vaccine evaluation Antonio E. Muruato, Camila R. Fontes-Garfias, Ping Ren, Mariano A. Garcia-Blanco, Vineet D. Menachery, Xuping Xie, Pei-Yong Shi
324 [GO] 2020―Aug―13 Face mask use in the general population and optimal resource allocation during the COVID-19 pandemic Colin J. Worby, Hsiao-Han Chang
325 [GO] 2020―Aug―06 Single-cell analysis of two severe COVID-19 patients reveals a monocyte-associated and tocilizumab-responding cytokine storm Chuang Guo, Bin Li, Huan Ma, Xiaofang Wang, Pengfei Cai, Qiaoni Yu, et al. (+18)
326 [GO] 2020―Aug―06 Morphogenesis and cytopathic effect of SARS-CoV-2 infection in human airway epithelial cells Na Zhu, Wenling Wang, Zhidong Liu, Chaoyang Liang, Wen Wang, Fei Ye, et al. (+13)
327 [GO] 2020―Jul―30 Activation and evasion of type I interferon responses by SARS-CoV-2 Xiaobo Lei, Xiaojing Dong, Ruiyi Ma, Wenjing Wang, Xia Xiao, Zhongqin Tian, et al. (+9)
328 [GO] 2020―Jul―24 Structural basis of RNA cap modification by SARS-CoV-2 Thiruselvam Viswanathan, Shailee Arya, Siu-Hong Chan, Shan Qi, Nan Dai, Anurag Misra, et al. (+6)
329 [GO] 2020―Jul―24 Structural analysis of the SARS-CoV-2 methyltransferase complex involved in RNA cap creation bound to sinefungin Petra Krafcikova, Jan Silhan, Radim Nencka, Evzen Boura
330 [GO] 2020―Jul―24 Patients with immune-mediated inflammatory diseases receiving cytokine inhibitors have low prevalence of SARS-CoV-2 seroconversion David Simon, Koray Tascilar, Gerhard Krönke, Arnd Kleyer, Mario M. Zaiss, Franz Heppt, et al. (+25)
331 [GO] 2020―Jul―17 Cryo-EM analysis of the post-fusion structure of the SARS-CoV spike glycoprotein Xiaoyi Fan, Duanfang Cao, Lingfei Kong, Xinzheng Zhang
332 [GO] 2020―Jul―15 Early triage of critically ill COVID-19 patients using deep learning Wenhua Liang, Jianhua Yao, Ailan Chen, Qingquan Lv, Mark Zanin, Jun Liu, et al. (+27)
333 [GO] 2020―Jul―14 SARS-CoV-2 proteome microarray for global profiling of COVID-19 specific IgG and IgM responses He-wei Jiang, Yang Li, Hai-nan Zhang, Wei Wang, Xiao Yang, Huan Qi, et al. (+4)
334 [GO] 2020―Jul―14 Transplacental transmission of SARS-CoV-2 infection Alexandre J. Vivanti, Christelle Vauloup-Fellous, Sophie Prevot, Veronique Zupan, Cecile S○, Jeremy Do Cao, et al. (+2)
335 [GO] 2020―Jul―14 Exploring the SARS-CoV-2 virus-host-drug interactome for drug repurposing Sepideh Sadegh, Julian Matschinske, David B. Blumenthal, Gihanna Galindez, Tim Kacprowski, Markus List, et al. (+11)
336 [GO] 2020―Jul―09 Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine candidate induces high neutralizing antibody titers in mice Paul F. McKay, Kai Hu, Anna K. Blakney, Karnyart Samnuan, Jonathan C. Brown, Rebecca Penn, et al. (+9)
337 [GO] 2020―Jul―08 Immunological and inflammatory profiles in mild and severe cases of COVID-19 Jin-Wen Song, Chao Zhang, Xing Fan, Fan-Ping Meng, Zhe Xu, Peng Xia, et al. (+16)
338 [GO] 2020―Jul―08 Seroprevalence of antibodies against SARS-CoV-2 among health care workers in a large Spanish reference hospital Alberto L. Garcia-Basteiro, Gemma Moncunill, Marta Tortajada, Marta Vidal, Caterina Guinovart, Alfons Jiménez, et al. (+32)
339 [GO] 2020―Jul―08 SARS-CoV-2 is transmitted via contact and via the air between ferrets Mathilde Richard, Adinda Kok, Dennis de Meulder, Theo M. Bestebroer, Mart M. Lamers, Nisreen M. A. Okba, et al. (+6)
340 [GO] 2020―Jul―06 Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia Sara De Biasi, Marianna Meschiari, Lara Gibellini, Caterina Bellinazzi, Rebecca Borella, Lucia Fidanza, et al. (+22)
341 [GO] 2020―Jul―06 An evaluation of COVID-19 serological assays informs future diagnostics and exposure assessment Corine H. GeurtsvanKessel, Nisreen M. A. Okba, Zsofia Igloi, Susanne Bogers, Carmen W. E. Embregts, Brigitta M. Laksono, et al. (+10)
342 [GO] 2020―Jul―01 High-altitude populations need special considerations for COVID-19 Arnar Breevoort, Giovanni A. Carosso, Mohammed A. Mostajo-Radji
343 [GO] 2020―Jun―24 Structural plasticity of SARS-CoV-2 3CL Mpro active site cavity revealed by room temperature X-ray crystallography Daniel W. Kneller, Gwyndalyn Phillips, Hugh M. O’Neill, Robert Jedrzejczak, Lucy Stols, Paul Langan, et al. (+3)
344 [GO] 2020―Jun―17 Cryo-EM structures of HKU2 and SADS-CoV spike glycoproteins provide insights into coronavirus evolution Jinfang Yu, Shuyuan Qiao, Runyu Guo, Xinquan Wang
345 [GO] 2020―Jun―10 Molecular structure analyses suggest strategies to therapeutically target SARS-CoV-2 Yi Zhang, Tatiana G. Kutateladze
346 [GO] 2020―Jun―01 Two linear epitopes on the SARS-CoV-2 spike protein that elicit neutralising antibodies in COVID-19 patients Chek Meng Poh, Guillaume Carissimo, Bei Wang, Siti Naqiah Amrun, Cheryl Yi-Pin Lee, Rhonda Sin-Ling Chee, et al. (+17)
347 [GO] 2020―May―29 Detection of air and surface contamination by SARS-CoV-2 in hospital rooms of infected patients Po Ying Chia, Kristen Kelli Coleman, Yian Kim Tan, Sean Wei Xiang Ong, Marcus Gum, Sok Kiang Lau, et al. (+19)
348 [GO] 2020―May―27 Vulnerabilities in coronavirus glycan shields despite extensive glycosylation Yasunori Watanabe, Zachary T. Berndsen, Jayna Raghwani, Gemma E. Seabright, Joel D. Allen, Oliver G. Pybus, et al. (+5)
349 [GO] 2020―May―20 Immunogenicity of a DNA vaccine candidate for COVID-19 Trevor R. F. Smith, Ami Patel, Stephanie Ramos, Dustin Elwood, Xizhou Zhu, Jian Yan, et al. (+53)
350 [GO] 2020―May―14 Publisher Correction: A human monoclonal antibody blocking SARS-CoV-2 infection Chunyan Wang, Wentao Li, Dubravka Drabek, Nisreen M. A. Okba, Rien van Haperen, Albert D. M. E. Osterhaus, et al. (+4)
351 [GO] 2020―May―04 A human monoclonal antibody blocking SARS-CoV-2 infection Chunyan Wang, Wentao Li, Dubravka Drabek, Nisreen M. A. Okba, Rien van Haperen, Albert D. M. E. Osterhaus, et al. (+4)
352 [GO] 2020―Apr―24 Neutralization of SARS-CoV-2 spike pseudotyped virus by recombinant ACE2-Ig Changhai Lei, Kewen Qian, Tian Li, Sheng Zhang, Wenyan Fu, Min Ding, Shi Hu
353 [GO] 2020―Mar―27 Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV Xiuyuan Ou, Yan Liu, Xiaobo Lei, Pei Li, Dan Mi, Lili Ren, et al. (+12)
354 [GO] 2020―Jan―10 Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV Timothy P. Sheahan, Amy C. Sims, Sarah R. Leist, Alexandra Schäfer, John Won, Ariane J. Brown, et al. (+13)


[de][en]

Last change 2021―Jun―30 20:09:44 UTC

© Daten-Quadrat 2021       Done in 0.132 sec